Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01909453 |
|---|---|
| Brief Title: | Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS) |
| First Submitted : | July 24, 2013 |
| First Submitted that Met QC Criteria : | July 24, 2013 |
| First Posted : | July 26, 2013 (Estimate) |
| Results First Submitted : | May 5, 2021 |
| Results First Submitted that Met QC Criteria : | July 9, 2021 |
| Results First Posted : | July 12, 2021 |
| Certification/Extension First Submitted : | October 12, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | October 12, 2017 |
| Certification/Extension First Posted : | October 17, 2017 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |